Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Iris Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01005472
What this trial is testing

Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant Melanoma

Who this might be right for
Metastatic Melanoma
Jonsson Comprehensive Cancer Center 16
Testing effectiveness (Phase 2)WithdrawnNCT05255666
What this trial is testing

Combination Liposomal Irinotecan and Pembrolizumab For Triple-Negative Breast Cancer (TNBC) With Brain Metastases (BM)

Who this might be right for
Triple Negative Breast CancerBrain Metastases
Washington University School of Medicine
Testing effectiveness (Phase 2)Ended earlyNCT00482911
What this trial is testing

Lenalidomide, Sunitinib, and Cyclophosphamide in Treating Patients With Stage IV Eye Melanoma

Who this might be right for
Intraocular MelanomaMalignant Conjunctival Neoplasm
National Institutes of Health Clinical Center (CC) 12
Not applicableUnknownNCT05587387
What this trial is testing

Change of Treatment Landscape and Survival in Metastatic Pancreatic Cancer After Nal-IRI in Republic of Korea

Who this might be right for
Pancreatic Neoplasms
Yonsei University 250
Testing effectiveness (Phase 2)Study completedNCT00089063
What this trial is testing

Vaccine Therapy With or Without Sargramostim in Treating Patients Who Have Undergone Surgery for Melanoma

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+6 more
National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT03810742
What this trial is testing

Nanoliposomal Irinotecan (Nal-IRI, ONIVYDE®) in Combination With TAS-102 (LONSURF®) in Refractory Solid Tumors

Who this might be right for
Refractory Solid Tumors
PharmaEngine 44
Testing effectiveness (Phase 2)Looking for participantsNCT06184698
What this trial is testing

Liposomal Irinotecan and Leucovorin/5-fluorouracil Plus Bevacizumab in Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hebei Medical University Fourth Hospital 173
Large-scale testing (Phase 3)UnknownNCT01249638
What this trial is testing

Cap+Bev vs Cap+Iri+Bev 1st-line Therapy in mCRC

Who this might be right for
Colorectal Cancer Metastatic
Ludwig-Maximilians - University of Munich 516
Large-scale testing (Phase 3)Temporarily pausedNCT00316745
What this trial is testing

IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Hokkaido Gastrointestinal Cancer Study Group 200
Testing effectiveness (Phase 2)Looking for participantsNCT05806931
What this trial is testing

Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer

Who this might be right for
Colon CancerRectal Cancer
Rutgers, The State University of New Jersey 50
Large-scale testing (Phase 3)Looking for participantsNCT05744219
What this trial is testing

Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial

Who this might be right for
SurgeryLiver MetastasesLiver Cancer+2 more
Jon Unosson 338
Not applicableWithdrawnNCT04561414
What this trial is testing

Objective to Evaluate the Safety and Effectiveness of LED Light Source System for Endoscopy in Ureteral Radiography

Who this might be right for
Lower Abdominal SurgeryPelvic Surgery
Stryker Orthopaedics
Large-scale testing (Phase 3)Study completedNCT01989572
What this trial is testing

Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery

Who this might be right for
Iris MelanomaMedium/Large Size Posterior Uveal MelanomaMucosal Melanoma+17 more
National Cancer Institute (NCI) 815
Testing effectiveness (Phase 2)Active Not RecruitingNCT03368963
What this trial is testing

TAS102 in Combination With NAL-IRI in Advanced GI Cancers

Who this might be right for
Colorectal AdenocarcinomaGastric AdenocarcinomaMetastatic Pancreatic Adenocarcinoma+11 more
Emory University 64
Testing effectiveness (Phase 2)Study completedNCT03328884
What this trial is testing

Evaluation of the Efficacy and Safety of Nal-IRI for Progressing Brain Metastases in Breast Cancer Patients

Who this might be right for
Breast Cancer Metastatic
MedSIR 55
Not applicableStudy completedNCT00952939
What this trial is testing

Study of Tumor Samples in Patients Undergoing Radiation Therapy or Surgery For Primary Melanoma of the Eye

Who this might be right for
Intraocular Melanoma
Case Comprehensive Cancer Center 150
Early research (Phase 1)Study completedNCT05628883
What this trial is testing

Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma

Who this might be right for
Metastatic MelanomaUnresectable MelanomaAcral Melanoma+7 more
H. Lee Moffitt Cancer Center and Research Institute 17
Testing effectiveness (Phase 2)WithdrawnNCT02785068
What this trial is testing

Evaluation of MM-151 + Nal-IRI + 5-FU + Leucovorin in RAS/RAF Wild-type Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Merrimack Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT01413191
What this trial is testing

Cixutumumab in Treating Patients With Metastatic Melanoma of the Eye

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small SizeIris Melanoma+3 more
National Cancer Institute (NCI) 18
Not applicableNot Yet RecruitingNCT07426510
What this trial is testing

IRIS: Risk-Based Imaging After Breast-Conserving Surgery

Who this might be right for
Breast Cancer
Umeå University 2,300
Next Page